Literature DB >> 2924161

Diazepam binding inhibitor-like immunoreactivity(51-70): distribution in human brain, spinal cord and peripheral tissues.

J A Ball1, M A Ghatei, K Sekiya, T Krausz, S R Bloom.   

Abstract

We have used a specific radioimmunoassay to describe the distribution of diazepam binding inhibitor-like immunoreactivity (DBI-IR(51-70) in human post-mortem tissues. In brain, highest concentrations were found in the cerebellum, amygdala, hippocampus, hypothalamus and substantia nigra. In the spinal cord, DBI-IR(51-70) was evenly distributed. In peripheral tissues, highest concentrations were found in the liver and kidney. Chromatographic analysis revealed several molecular forms of DBI-IR(51-70) the major form being of greater molecular weight and hydrophobicity than the synthetic fragment peptide. In peripheral tissues, but not in the CNS, a small peak of immunoreactivity was indistinguishable from the synthetic peptide. DBI-IR(51-70) is therefore widespread, but tissue processing may be different.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924161     DOI: 10.1016/0006-8993(89)91632-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Endozepine-4 levels are increased in hepatic coma.

Authors:  Giulia Malaguarnera; Marco Vacante; Filippo Drago; Gaetano Bertino; Massimo Motta; Maria Giordano; Michele Malaguarnera
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 2.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

3.  Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain.

Authors:  H Alho; P Bovolin; E Slobodyansky
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

4.  Effect of intranigral dosage with delta-sleep-inducing peptide and its analogs on movement and convulsive activity in rats.

Authors:  A A Shandra; R S Godlevskii; A I Vast'yanov; A I Brusentsov; I I Mikhaleva; I A Prudchenko; V N Zaporozhan
Journal:  Neurosci Behav Physiol       Date:  1996 Nov-Dec

5.  Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus.

Authors:  Connor D Courtney; Catherine A Christian
Journal:  Neuroscience       Date:  2018-07-19       Impact factor: 3.590

6.  Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice.

Authors:  Ammar L Ujjainwala; Connor D Courtney; Natalia M Wojnowski; Justin S Rhodes; Catherine A Christian
Journal:  J Neurosci Res       Date:  2019-01-25       Impact factor: 4.164

7.  The characterization of two diazepam binding inhibitor (DBI) transcripts in humans.

Authors:  M Kolmer; A Rovio; H Alho
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.

Authors:  Claire Leroy; Pierrick Poisbeau; A Florence Keller; Astrid Nehlig
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

9.  Acyl-CoA binding proteins; structural and functional conservation over 2000 MYA.

Authors:  Nils J Faergeman; Majken Wadum; Søren Feddersen; Mark Burton; Birthe B Kragelund; Jens Knudsen
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

10.  Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study.

Authors:  Thomas Clavier; Marie-Christine Tonon; Anne Foutel; Emmanuel Besnier; Antoine Lefevre-Scelles; Fabrice Morin; Pierrick Gandolfo; Jean-Jacques Tuech; Muriel Quillard; Benoit Veber; Bertrand Dureuil; Hélène Castel; Vincent Compère
Journal:  Crit Care       Date:  2014-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.